Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

German program using whole genome sequencing to diagnose rare diseases and cancer risk

A program at the University Hospital of Tübingen is the first in Germany to use whole genome sequencing (WGS) to improve the diagnosis of rare diseases and hereditary cancers.

Pfizer and BioNTech start trialing booster shot for COVID-19 vaccine

Pfizer and BioNTech have begun evaluating the safety and immunogenicity of a third dose of their mRNA vaccine, to understand the effect of a booster on immunity against current and emerging virus variants.

Moderna to take new variant-specific COVID-19 vaccine into Phase 1 trials

Moderna’s variant-specific vaccine – designed to tackle the South Africa variant – has been shipped to the US National Institutes of Health (NIH) for a Phase 1 clinical trial.

FDA says J&J COVID-19 vaccine is effective and safe

The FDA has outlined its analysis of Johnson & Johnson's single-shot COVID-19 vaccine, ahead of a meeting of the Vaccines and Related Biological Products Advisory Committee Meeting to assess the candidate's application for Emergency Use...

Coming of Phage: Clinical trial underscores safety of technology battling E. coli triggered UTIs

Locus Biosciences says the results of its early stage clinical trial for CRISPR-enhanced bacteriophage therapy shows its precision medicine asset is safe and well tolerated.

Moderna announces capital investments to boost COVID-19 vaccine production

Moderna has announced new capital investments to increase COVID-19 vaccine manufacturing capacity: targeting global capacity of 1.4 billion doses in 2022.